InvestorsHub Logo
Followers 19
Posts 1027
Boards Moderated 0
Alias Born 06/28/2013

Re: None

Monday, 03/03/2014 2:27:41 PM

Monday, March 03, 2014 2:27:41 PM

Post# of 48316
Things are progressing rather nicely. Great outlook for this year.
Apart from data announcements on MCC and Mel trials, I eagerly anticipate the Anti-Pd-1 + Immunopulse combo trial; This will be a true breakthrough.
I wonder if the new non-cutaneous tumor trial will be the one to involve anti-pd-1s.
Would an anti-pd-1 trial be pending partnership? (Punit stated a month ago that we're looking for an anti-pd-1 partner). If the new new non-cutaneous tumor trial does indeed involve Anti-Pd-1s, does this then mean that we're near finalization of a partnership?? Maybe. Maybe not.
We'll see.
Either way, great things ahead/